ASPIRE is carfilzomib in combination with Lenalidomide, and Dexamethasone in relapsed MM while FOCUS is the only randomized trial where carfilzomib as single agent in rrMM.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.